Clinical Trial

Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy

Study acronym: EXPAND
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain relief or were unsuitable due to contraindications or intolerance.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-11 -> 2028-09 2026-06-26
minor Completion pushed: 2027-11 -> 2028-09 2026-06-26
Trial Details
NCT Number NCT06956014
Lead Sponsor Vertanical GmbH
Conditions Lumbosacral Radiculopathy
Enrollment 810 participants
Start Date 2026-09
Primary Completion 2028-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-25